Skip to content

Ultrasound Index Fat Fraction

Comparison of the Ultrasound Index Fat Fraction (FAT PLUS) With the MRI-PDFF Score for Quantification of Hepatic Steatosis.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06373796
Acronym
FAT-PLUS
Enrollment
88
Registered
2024-04-18
Start date
2024-06-06
Completion date
2025-01-30
Last updated
2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Steatosis of Liver

Brief summary

The objective is to compare the ultrasound index fat fraction (FAT PLUS), derived from several ultrasound biomarkers, with the gold-standard imaging exam for liver fat content evaluation (MRI-PDFF) in patients to quantify the hepatic steatosis.

Interventions

DEVICEEchographic scan

Liver ultrasound exam

Sponsors

SuperSonic Imagine
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject is ≥ 18 years old. * Subject is able to understand and sign the Informed Consent Form. * Subject is able to stand and walk independently. * Subject must have at least one or more routine ultrasound imaging procedures of the abdomen, at one of the participating study sites. * Subject must have at least one routine liver MRI with PDFF score performed within 30 days before or after the ultrasound examination * Subject is affiliated to National Social Insurance or a Health Insurance Regimen

Exclusion criteria

* Subject is unable or unwilling to adhere to Study procedures * Subject is unable to understand the Informed Consent * Subject is unable to express its consent * Subject is under legal protection * Subject is deprived of liberty by judicial or administrative decision * Subject undergoes psychiatric treatment under constraint * Subject is pregnant or breastfeeding * Subject has latex allergy * Subject has an open wound, cut, and/or a rash which would preclude an ultrasound imaging procedure

Design outcomes

Primary

MeasureTime frameDescription
FAT PLUS3 monthsThe objective is to compare the ultrasound index fat fraction (FAT PLUS), derived from several ultrasound biomarkers, with the gold-standard imaging exam for liver fat content evaluation (MRI-PDFF) in patients to quantify the hepatic steatosis.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026